期刊
ACS CENTRAL SCIENCE
卷 8, 期 9, 页码 1306-1317出版社
AMER CHEMICAL SOC
DOI: 10.1021/acscentsci.2c00533
关键词
-
资金
- National Key Research and Development Program of China [2019YFA0905603]
- National Natural Science Foundation of China [22135005, 52131302, 51833007]
This study developed a bioorthogonal-mediated bacterial delivery strategy to enhance the colonization of probiotics by modulating bacterial adhesion between probiotics and gut inhabitants, thereby improving the clinical treatment efficacy of oral bacterial therapy.
Clinical treatment efficacy of oral bacterial therapy has been largely limited by insufficient gut retention of probiotics. Here, we developed a bioorthogonal-mediated bacterial delivery strategy for enhancing probiotics colonization by modulating bacterial adhesion between probiotics and gut inhabitants. Metabolic amino acid engineering was applied to metabolically incorporate azido-decorated D-alanine into peptidoglycans of gut inhabitants, which could enable in situ bioorthogonal conjugation with dibenzocyclooctyne (DBCO)-modified probiotics. Both in vitro and in vivo studies demonstrated that the occurrence of the bioorthogonal reaction between azido-and DBCO-modified bacteria could result in obvious bacterial adhesion even in a complex physiological environment. DBCO-modified Clostridium butyricum (C. butyricum) also showed more efficient reservation in the gut and led to obvious disease relief in dextran sodium sulfate-induced colitis mice. This strategy highlights metabolically modified gut inhabitants as artificial reaction sites to bind with DBCO-decorated probiotics via bioorthogonal reactions, which shows great potential for enhancing bacterial colonization.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据